Osteoporotic fractures: an unrecognized adverse event of immune checkpoint inhibitors?
Journal for ImmunoTherapy of Cancer · 2024-07 · 12 (7) · e009309
DOI: 10.1136/jitc-2024-009309 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 20.07.2024. Verfasst von Manar Elsayed und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Osteoporotic Fractures. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR - ICR / Cancer Research Society Partnership - Research Grants.
Abstract (Originalsprache)
The widespread use of immune checkpoint inhibitors (ICIs) in clinical practice has broadened our understanding of their immune-related adverse events (irAEs). IrAEs, including musculoskeletal adverse events, remain a significant concern. While ICI-associated arthritis is a well-documented musculoskeletal side effect of ICI therapy, the direct effects of ICIs on bone in patients with cancer are poorly understood. There is emerging evidence to support the hypothesis that ICIs adversely impact bone turnover and can lead to osteoporosis and fragility fractures, which are not currently recognized as irAEs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Department of Medicine, University of Alberta, Edmonton, Alberta, Canada cye@ualberta.ca.
ORCID-Profile: Manar Elsayed, Carrie Ye
Förderung
- CIHR - ICR / Cancer Research Society Partnership - Research Grants
Zitieren
APA
Elsayed, M., & Ye, C. (2024). Osteoporotic fractures: an unrecognized adverse event of immune checkpoint inhibitors?. Journal for ImmunoTherapy of Cancer, 12(7), e009309. https://doi.org/10.1136/jitc-2024-009309
Vancouver
Elsayed M, Ye C. Osteoporotic fractures: an unrecognized adverse event of immune checkpoint inhibitors?. Journal for ImmunoTherapy of Cancer. 2024;12(7):e009309. doi:10.1136/jitc-2024-009309
BibTeX
@article{Elsayed2024,
author = {Elsayed, Manar and Ye, Carrie},
title = {Osteoporotic fractures: an unrecognized adverse event of immune checkpoint inhibitors?},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
volume = {12},
number = {7},
pages = {e009309},
doi = {10.1136/jitc-2024-009309}
}
EUVIMED